Coronavirus: Cancer surgery delays risk ‘thousands’ of deaths

The NHS must ensure cancer-surgery delays do not cost more lives than the number of Covid-19 patients saved, the Institute of Cancer Research says.

In some cancers, a three-month delay could make the difference between a tumour being curable or not, Prof Clare Turnbull said.

And her modelling suggested delaying surgery risked thousands of additional deaths.

NHS England is already urging people to seek help for worrying symptoms.

Cancer doctors have told BBC News of having to make difficult decisions to postpone some patients' care during the coronavirus crisis.

But by the end of April, cancer referrals had dropped by an estimated 70%.

And as normal service resumed, the NHS should prioritise "certain cancer types in particular", Prof Turnbull said.

Lung and colorectal cancers, for example, were particularly fast moving.

But for others, such as prostate and certain breast cancers, treatment could more safely be delayed.

For every 10 Covid-19 patients whose lives were saved in hospital, four cancer patients could die, according to the ICR study, if all tumour-removal surgeries are delayed by six months.

Every year, there are 95,000 operations to remove common cancers in adults in England.

And more than 80,000 of these patients go on to survive for at least five years.

But a three-month delay would lead to almost 5,000 excess deaths.

And a six month delay could lead to almost 11,000.

Trusts have been told all essential cancer treatments must continue despite the NHS focus on coronavirus.

An NHS England official said: "Vital tests and treatments are going ahead in a safe way for thousands of patients, including by introducing Covid-protected cancer hubs.

"The NHS has now sRead More – Source

[contf] [contfnew]